NUVECTIS PHARMA
Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer. Nuvectis is led by a management team comprised of industry veterans with broad and extensive drug development experience, and a proven track record of clinical and regulatory success. By leveraging our core competencies of target selection, drug profiling, and clinical and regulatory execution we are building our pipeline of product candidates for development in various oncology indications.
NUVECTIS PHARMA
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Fort Lee, New Jersey, United States
Country:
United States
Website Url:
http://www.nuvectis.com
Status:
Active
Contact:
(201) 614-3151
Total Funding:
31.2 M USD
Technology used in webpage:
Mobile Non Scaleable Content ReCAPTCHA Google Google Cloud GoDaddy SSL Java EE Visa New Relic Google Cloud Global Multi-Region MasterCard
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.nuvectis.com Semrush global rank: 5.49 M Semrush visits lastest month: 1.56 K
- Host name: box2455.bluehost.com
- IP address: 69.195.76.217
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Nuvectis Pharma"
Nuvectis Pharma - Crunchbase Company Profile & Funding
Nuvectis Pharma is a bio-pharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer. Nuvectis is led by a management team comprised of …See details»
About - Nuvectis Pharma, Inc.
NUVECTIS PHARMA, INC. is a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet …See details»
Investors - Nuvectis Pharma, Inc.
Sep 14, 2023 Sign up for email updates. Enter your email, choose the content of interest and click Subscribe.See details»
Nuvectis Pharma - LinkedIn
Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in ...See details»
Nuvectis Org Chart + Executive Team - The Official Board
Nuvectis has 6 executives. Nuvectis; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org chart. To continue, you can …See details»
Nuvectis Pharma - AnnualReports.com
Nuvectis Pharma is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. It is their mission to improve the outcomes for …See details»
Nuvectis Pharma - 2025 Company Profile - Tracxn
Mar 28, 2025 Nuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Acquires 240,000 Shares of StockMarketBeat • Feb 13, 2025 • Nuvectis Pharma Nuvectis Pharma Announces …See details»
NVCT - Nuvectis Pharma, Inc. Stock - Stock Price, Institutional ...
Nuvectis Pharma, Inc. (NasdaqCM:NVCT) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. …See details»
Nuvectis Pharma Company Profile - Office Locations, Competitors …
Oct 29, 2024 Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment. It develops NXP800, an …See details»
Nuvectis Pharma (NVCT) Company Profile & Description - Stock …
Feb 4, 2022 Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical …See details»
Nuvectis Pharma, Inc. (NVCT) Company Profile & Facts - Yahoo …
See the company profile for Nuvectis Pharma, Inc. (NVCT) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Nuvectis Pharma - Overview, News & Similar companies - ZoomInfo
Mar 21, 2024 Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes Fort Lee, NJ , June 20, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) …See details»
NUVECTIS PHARMA, INC. CORPORATE GOVERNANCE GUIDELINES
NUVECTIS PHARMA, INC. CORPORATE GOVERNANCE GUIDELINES . The following Corporate Governance Guidelines (these “Guidelines”) have been adopted by the Board of …See details»
Nuvectis - Products, Competitors, Financials, Employees, …
Summary About Nuvectis Pharma Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs …See details»
Nuvectis Pharma, Inc.: Shareholders, Shareholding Structure ...
8ea4362025ab38231e.UWAkNWV_3Do7H7MqISSZ0W5hRJ5lVgzl8YaRR5aAV28.Y1BGfVATnmxoJ-Z7F0zbqDE5I_AtEn6ExdfLHtTrZV4aI0lDEheIf3Npiw Log inSee details»
Nuvectis Pharma - Contacts, Employees, Board Members
Organization. Nuvectis Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Nuvectis Pharma Raises $15 Million and In-Licenses Exclusive …
– Nuvectis Pharma, Inc. (the “Company” or “Nuvectis”), a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical …See details»
Maxim Group Initiates Coverage of Nuvectis Pharma (NVCT) with …
3 days ago As of April 2, 2025, the average one-year price target for Nuvectis Pharma is $16.32/share. The forecasts range from a low of $11.11 to a high of $19.95. The forecasts …See details»
Nuvectis Pharma (NVCT) Earnings Date and Reports 2025
2 days ago Nuvectis Pharma posted Q4 2024 earnings on March 4, 2025, reporting an EPS of -$0.36, which missed analysts' consensus estimates of -$0.28 by $0.08. With a trailing EPS of …See details»
Press Releases - Nuvectis Pharma, Inc.
Mar 26, 2025 About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of …See details»